Bradley Kreger Net Worth

The estimated Net Worth of Bradley Allen Kreger is at least $1.7 Million dollars as of 22 February 2022. Mr. Kreger owns over 7,753 units of Standard BioTools Inc stock worth over $350,565 and over the last 6 years he sold FLDM stock worth over $0. In addition, he makes $1,352,300 as Senior Vice President and Global Operations at Standard BioTools Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr. Kreger FLDM stock SEC Form 4 insiders trading

Bradley has made over 12 trades of the Standard BioTools Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 7,753 units of FLDM stock worth $28,764 on 22 February 2022.

The largest trade he's ever made was exercising 57,752 units of Standard BioTools Inc stock on 20 May 2021 worth over $214,260. On average, Bradley trades about 8,402 units every 59 days since 2019. As of 22 February 2022 he still owns at least 94,492 units of Standard BioTools Inc stock.

You can see the complete history of Mr. Kreger stock trades at the bottom of the page.

Bradley Kreger biography

Bradley Allen Kreger serves as Senior Vice President, Global Operations of the Company. Mr. Kreger was Senior Director, Operations, Clinical Sequencing Division at Thermo Fisher Scientific, a life sciences company. From 1995 to December 2016, Mr. Kreger held various staff and management positions at Affymetrix, a biotechnology company, including VP, Reagent Manufacturing & Global Process Engineering, Senior Director, Global Process Engineering and Manufacturing Science, and Director, Global Process Engineering and Manufacturing Science. Mr. Kreger received a MBA from Western Governors University and a B.S. in Biotechnology and Business from Charter Oak State College.

What is the salary of Bradley Kreger?

As the Senior Vice President and Global Operations of Standard BioTools Inc, the total compensation of Bradley Kreger at Standard BioTools Inc is $1,352,300. There are 3 executives at Standard BioTools Inc getting paid more, with Stephen Linthwaite having the highest compensation of $3,713,060.

How old is Bradley Kreger?

Bradley Kreger is 45, he's been the Senior Vice President and Global Operations of Standard BioTools Inc since 2018. There are 13 older and no younger executives at Standard BioTools Inc. The oldest executive at Standard BioTools Inc is Vikram Jog, 65, who is the Chief Financial Officer.

What's Bradley Kreger's mailing address?

Bradley's mailing address filed with the SEC is C/O FLUIDIGM CORPORATION, 2 TOWER PLACE, STE 2000, SOUTH SAN FRANCISCO, CA, 94080.

Insiders trading at Standard BioTools Inc

Over the last 14 years, insiders at Standard BioTools Inc have traded over $29,087,682 worth of Standard BioTools Inc stock and bought 4,143,303 units worth $24,269,186 . The most active insiders traders include Easterly Partners Llcle Par..., Capital Strategies, L.P.Lev..., and Samuel D Colella. On average, Standard BioTools Inc executives and independent directors trade stock every 9 days with the average trade being worth of $72,208. The most recent stock trade was executed by Nicolas Barthelemy on 1 April 2022, trading 20,993 units of FLDM stock currently worth $78,514.

What does Standard BioTools Inc do?

Fluidigm focuses on the most pressing needs in translational and clinical research, including cancer, immunology, and immunotherapy. Using proprietary CyTOF® and microfluidics technologies, it develops, manufactures, and markets multi-omic solutions to drive meaningful insights in health and disease, identify biomarkers to inform decisions, and accelerate the development of more effective therapies. Its customers are leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide. Together with them, the Company strives to increase the quality of life for all.

Complete history of Mr. Kreger stock trades at Standard BioTools Inc

Standard BioTools Inc executives and stock owners

Standard BioTools Inc executives and other stock owners filed with the SEC include:

• Stephen Linthwaite,
  President, Chief Executive Officer, Director
• Colin McCracken,
  Chief Commercial Officer
• Vikram Jog,
  Chief Financial Officer
• Bradley Kreger,
  Senior Vice President, Global Operations
• Nicholas Khadder,
  Senior Vice President, General Counsel, Corporate Secretary
• Colin McCracken,
  Chief Commercial Officer
• Vikram Jog,
  Chief Financial Officer
• Bradley Allen Kreger,
  Sr. VP of Global Operations
• Gerhard Burbach,
  Independent Director
• Nicolas Barthelemy,
  Independent Director
• Carlos Paya,
  Independent Chairman of the Board
• Laura Clague,
  Independent Director
• Bill Colston,
  Independent Director
• Angela Peters,
  Chief HR Officer
• Mark Spearman,
  Sr. Director of Corp. Communications
• Peter DeNardo,
  Investor Relations
• Andrew Quong,
  Chief Science Officer
• Dr. Stephen R. Quake D.phil., Ph.D.,
  Co-Founder & Chairman of Advisory Board
• Venture Capital I Lpversant...,
  
• Capital Strategies, L.P.Lev...,
  
• John A Young,
  Director
• Steven Mc Phail,
  GM, PRODUCTION GENOMICS
• Mai Chan Yow,
  VP, WW Mfg & MD-Singapore
• Samuel D Colella,
  Director
• Jennifer Ling Lee,
  See Remarks
• Patrick S Jones,
  Director
• Gajus Vincent Worthington,
  President & CEO
• William Maxwell Smith,
  VP, Legal Affairs & GC
• Marc Unger,
  See Remarks
• Evan/ Fa Jones,
  Director
• Capital Strategies, L.P.Lev...,
  
• Capital Strategies, L.P.Lev...,
  
• Capital Strategies, L.P.Lev...,
  
• Ana K. Stankovic,
  Director
• Robert C Jones,
  Exec. VP, Research & Dev.
• Raymond J Whitaker,
  Director
• Kenneth J Nussbacher,
  Director
• Investments Pte Ltd.Biomedi...,
  
• Jeremy Loh,
  Director
• Partners, L.P.Euclid Sr Bio...,
  
• Easterly Partners Llcle Par...,